Eam Global Investors LLC Protagonist Therapeutics, Inc Transaction History

Eam Global Investors LLC

  • $402 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$12.95 - $49.69 $908,895 - $3.49 Million
-70,185 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$25.57 - $44.88 $1.79 Million - $3.15 Million
70,185 New
70,185 $3.15 Million
Q1 2021

May 11, 2021
SELL
$19.02 - $31.15 $1.18 Million - $1.93 Million
-62,047 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$18.49 - $25.13 $818,885 - $1.11 Million
-44,288 Reduced 41.65%
62,047 $1.25 Million
Q3 2020

Nov 13, 2020
BUY
$15.19 - $22.4 $1.62 Million - $2.38 Million
106,335 New
106,335 $2.08 Million

Others Institutions Holding PTGX

# of Institutions
212
Shares Held
59.1M
Call Options Held
19K
Put Options Held
107K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email